Truist Securities Reiterates Iovance Biotherapeutics (IOVA) Buy Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on September 15, 2023, Truist Securities reiterated coverage of Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy recommendation.
